Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Perspectives
Open Access

Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

Yue-miao Zhang and Hong Zhang
CJASN July 2020, 15 (7) 1044-1046; DOI: https://doi.org/10.2215/CJN.04370420
Yue-miao Zhang
Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China Institute of Nephrology, Peking University, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading
  • COVID-19
  • kidney involvement
  • severe acute respiratory syndrome coronavirus 2
  • human ACE2
  • genetic perspective

The outbreak of severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic with an exponential growth rate. A recent study found SARS-CoV-2 nucleocapsid protein in kidney tubules of patients infected with SARS-CoV-2 (B. Diao, C.H. Wang, R.S. Wang, Z.Q. Feng, Y.J. Tan, H.M. Wang, et al.: Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection [preprint posted online April 10, 2020]. medRxiv doi:10.1101/2020.03.04.20031120), providing direct evidence of kidney susceptibility to SARS-CoV-2. However, the full extent of clinical manifestations with kidney disease and prognoses in patients with the infection remains largely unknown. Because CKD affects 10%–15% of the global population, we urgently need to clarify (1) who is susceptible to kidney damage, (2) what the clinical manifestations are and how they should be diagnosed at an early stage, and (3) how the patients should be monitored during follow-up.

The recent development of large-scale “omics” analytic approaches provides a large number of publicly available data sets, such as the spatial characterization of the transcriptome and proteome in different tissues of the human body (1) and expression quantitative trait loci (eQTLs) in kidney compartments (2,3). Human angiotensin-converting enzyme 2 (ACE2) has been identified as the functional receptor of SARS-CoV-2 (4). Thus, genetic analysis of the spatial distribution of human ACE2 expression and its genetic determinants in kidney provides a promising opportunity for predicting kidney involvement during SARS-CoV-2 infection at an early stage.

We first determined the gene and protein expression levels of human ACE2 along with its spatial characterization in kidney compartments in The Human Protein Atlas (https://www.proteinatlas.org/) (1). Human ACE2 was highly expressed in multiple organs, including the kidney. This was consistent with the fact that, although SARS-CoV-2 infection primarily manifests as acute respiratory illness, it has also been detected in urine samples. In the kidney, human ACE2 was specifically highly expressed in tubules rather than in glomeruli (Figure 1), suggesting tubular injury as the main consequence of SARS-CoV-2 infection in the kidney. This was validated in a recent study that observed macrophage infiltration and acute tubular damage but no severe glomerular injury (B. Diao, C.H. Wang, R.S. Wang, Z.Q. Feng, Y.J. Tan, H.M. Wang, et al.: Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection [preprint posted online April 10, 2020]. medRxiv doi:10.1101/2020.03.04.20031120).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Human ACE2 was highly stained in tubules rather than in glomeruli in human kidney tissue. These results were derived from the Human Protein Atlas database (https://www.proteinatlas.org/). Protein expression in normal kidney tissue from six patients was detected by immunohistochemistry using antibodies HPA000288 (rabbit; Sigma) and CAB026174 (mouse; R&D Systems). The ages of patients range from 16 to 70 years old. As shown, human ACE2 was not detected in glomeruli but was highly stained in tubules.

We then searched for the genetic determinants of human ACE2 expression in kidney tubulointerstitial tissue to evaluate the susceptibility to kidney damage in patients infected with SARS-CoV-2. Gillies et al. (2) provided thousands of kidney-specific eQTLs in manually microdissected glomerular (n=136) and tubulointerstitial (n=166) compartments from patients with proteinuric kidney diseases, such as FSGS, minimal change disease, and membranous nephropathy (NephQTL database, http://nephqtl.org/). After searching, 49 variants with P<0.05 were detected; the lowest P value detected was 7.89×10−3, but none of the variants achieved a Bonferroni-corrected threshold P<1.02×10−3. Likewise, there were no significant eQTLs from microdissected tubulointerstitial compartments (n=119) from healthy human kidneys of white subjects undergoing surgical nephrectomy (Human Kidney eQTL Atlas, http://susztaklab.com/eqtl) (3). Therefore, the gene expression of human ACE2 in tubules is less likely to be affected by genetic variants, meaning that the general population could potentially be susceptible to consequences from SARS-CoV-2 infection on the kidney.

Finally, we applied our genetic analysis pipeline to other viral infections with well known receptors (e.g., hepatitis B and D viruses). As expected, the cellular receptor of the hepatitis B and D viruses, sodium taurocholate cotransporting polypeptide, was highly specifically expressed in human hepatocytes. The strictly hepatotropic character of hepatitis B and D viruses suggests that SARS-CoV-2 may be nephrotropic. In fact, previous studies have shown a considerable degree of kidney involvement in SARS and Middle East respiratory syndrome (MERS), including AKI and kidney failure (5). Both SARS-CoV RNA and viral particles have been observed in kidney tubules from SARS autopsies (6), indicating direct infection and replication in the kidney. Dipeptidyl peptidase-4, the cellular receptor of MERS-CoV, is also expressed in kidney tubules. There is also evidence supporting kidney infection and induction of apoptosis by MERS-CoV in human ex vivo organ culture (7). The underlying mechanism of kidney involvement in patients infected with SARS-CoV-2 is still unclear, but the existing evidence suggests that the direct infection of SARS-CoV-2 in kidney tubules may play a role. It is still unclear whether the kidney may be a hidden reservoir for SARS-CoV-2 and if the virus will persistently replicate in the kidney. Thus, more attention should be given to the long-term sequelae of SARS-CoV-2 infection and intensive monitoring of kidney function seems necessary. However, it should be noted that, in contrast to the relatively high expression of the sodium taurocholate cotransporting polypeptide receptor of hepatitis B and D viruses in blood cells (normalized expression ranges from 0.1 to 2.7), the normalized expression levels of human ACE2 ranges from 0.0 to 0.3 (https://www.proteinatlas.org/), implying that SARS-CoV-2 has a relatively low viremic rate. It was reported that viral RNA was detectable by real-time PCR of plasma samples in about 15% (two of 13) of patients in the intensive-care unit and 14% (four of 28) of other patients (8). However, the clinical significance of viral RNA in plasma for affecting kidney manifestations and whether the virus itself is also present in plasma must still be determined. Thus, although SARS-CoV-2 showed nephrotropic effects, the rate of kidney injury directly caused by SARS-CoV-2 needs further evaluation.

The spatial characteristics of RNA, protein expression of human ACE2, and kidney-specific eQTL analysis indicate that SARS-COV-2 could affect the kidneys of the general population infected with the virus, tubular injury might be the main pathologic manifestation of kidney involvement, and there is a necessity for intensive monitoring of kidney function during follow-up. However, because of a lack of routine screening and monitoring of kidney function, the exact incidence of kidney involvement is still unclear. Current studies have mainly focused on AKI, which is defined by increased serum creatinine or urine output criteria, with an incidence rate varying from 0.3% to 15%. Although, as mentioned above, there might be a relatively lower degree of direct kidney effects of SARS-CoV-2 compared with the effects of hepatitis B and D viruses on the liver. SARS-CoV-2–related cytokine storm and sepsis that lead to tubular and endothelial injury may also be potential pathways of kidney damage (e.g., microthrombi) (9). Thus, to determine the exact incidence rate of kidney injury due to SARS-CoV-2 infection, it is necessary to screen patients who are infected for signs of kidney damage by performing tests commonly used in the clinic, such as measuring serum creatinine or performing dipstick tests for proteinuria and hematuria. Additionally, because human ACE2 is strictly expressed in kidney tubules, the early kidney damage biomarkers such as neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and IL-18 could also be considered for further clinical evaluation. Furthermore, because accumulated SARS-CoV-2 nucleocapsid protein was detected in kidney tubules from autopsies performed on patients with SARS-CoV-2, patients diagnosed with de novo kidney disease could be tested for virus RNA or viral antigen in urine as a possible surrogate for early diagnosis or for monitoring of disease severity. Finally, it needs to be determined whether patients with preexisting kidney disease are more susceptible to a progressive disease course or a higher risk of acute kidney failure. A global effort to better understand kidney injury due to SARS-CoV-2 is warranted.

In conclusion, we provide a genetic pipeline to help explore the roadmap for kidney involvement in SARS-CoV-2 infection. This study highlights the benefits of integrating omics data sets with eQTLs to identify the roles of target genes in disease pathogenesis; this approach will also be applicable for other viruses with well known receptors.

Disclosures

Dr. H. Zang and Dr. Y. Zhang have nothing to disclose.

Funding

This study was supported by National Natural Science Foundation of China grant 81800636.

Acknowledgments

The authors would like to thank Lin Wang for helpful discussion and editors and reviewers at CJASN for valuable comments and suggestions.

The content of this article does not reflect the views or opinions of the American Society of Nephrology (ASN) or CJASN. Responsibility for the information and views expressed therein lies entirely with the author(s).

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • Copyright © 2020 by the American Society of Nephrology

References

  1. ↵
    1. Uhlén M,
    2. Fagerberg L,
    3. Hallström BM,
    4. Lindskog C,
    5. Oksvold P,
    6. Mardinoglu A,
    7. Sivertsson Å,
    8. Kampf C,
    9. Sjöstedt E,
    10. Asplund A,
    11. Olsson I,
    12. Edlund K,
    13. Lundberg E,
    14. Navani S,
    15. Szigyarto CA,
    16. Odeberg J,
    17. Djureinovic D,
    18. Takanen JO,
    19. Hober S,
    20. Alm T,
    21. Edqvist PH,
    22. Berling H,
    23. Tegel H,
    24. Mulder J,
    25. Rockberg J,
    26. Nilsson P,
    27. Schwenk JM,
    28. Hamsten M,
    29. von Feilitzen K,
    30. Forsberg M,
    31. Persson L,
    32. Johansson F,
    33. Zwahlen M,
    34. von Heijne G,
    35. Nielsen J,
    36. Pontén F
    : Proteomics. Tissue-based map of the human proteome. Science 347: 1260419, 2015pmid:25613900
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Gillies CE,
    2. Putler R,
    3. Menon R,
    4. Otto E,
    5. Yasutake K,
    6. Nair V,
    7. Hoover P,
    8. Lieb D,
    9. Li S,
    10. Eddy S,
    11. Fermin D,
    12. McNulty MT,
    13. Hacohen N,
    14. Kiryluk K,
    15. Kretzler M,
    16. Wen X,
    17. Sampson MG
    ; Nephrotic Syndrome Study Network (NEPTUNE): An eQTL landscape of kidney tissue in human nephrotic syndrome. Am J Hum Genet 103: 232–244, 2018pmid:30057032
    OpenUrlCrossRefPubMed
  3. ↵
    1. Qiu C,
    2. Huang S,
    3. Park J,
    4. Park Y,
    5. Ko YA,
    6. Seasock MJ,
    7. Bryer JS,
    8. Xu XX,
    9. Song WC,
    10. Palmer M,
    11. Hill J,
    12. Guarnieri P,
    13. Hawkins J,
    14. Boustany-Kari CM,
    15. Pullen SS,
    16. Brown CD,
    17. Susztak K
    : Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med 24: 1721–1731, 2018pmid:30275566
    OpenUrlCrossRefPubMed
  4. ↵
    1. Zhou P,
    2. Yang XL,
    3. Wang XG,
    4. Hu B,
    5. Zhang L,
    6. Zhang W,
    7. Si HR,
    8. Zhu Y,
    9. Li B,
    10. Huang CL,
    11. Chen HD,
    12. Chen J,
    13. Luo Y,
    14. Guo H,
    15. Jiang RD,
    16. Liu MQ,
    17. Chen Y,
    18. Shen XR,
    19. Wang X,
    20. Zheng XS,
    21. Zhao K,
    22. Chen QJ,
    23. Deng F,
    24. Liu LL,
    25. Yan B,
    26. Zhan FX,
    27. Wang YY,
    28. Xiao GF,
    29. Shi ZL
    : A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579: 270–273, 2020pmid:32015507
    OpenUrlCrossRefPubMed
  5. ↵
    1. Arabi YM,
    2. Arifi AA,
    3. Balkhy HH,
    4. Najm H,
    5. Aldawood AS,
    6. Ghabashi A,
    7. Hawa H,
    8. Alothman A,
    9. Khaldi A,
    10. Al Raiy B
    : Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med 160: 389–397, 2014pmid:24474051
    OpenUrlCrossRefPubMed
  6. ↵
    1. Gu J,
    2. Gong E,
    3. Zhang B,
    4. Zheng J,
    5. Gao Z,
    6. Zhong Y,
    7. Zou W,
    8. Zhan J,
    9. Wang S,
    10. Xie Z,
    11. Zhuang H,
    12. Wu B,
    13. Zhong H,
    14. Shao H,
    15. Fang W,
    16. Gao D,
    17. Pei F,
    18. Li X,
    19. He Z,
    20. Xu D,
    21. Shi X,
    22. Anderson VM,
    23. Leong AS
    : Multiple organ infection and the pathogenesis of SARS. J Exp Med 202: 415–424, 2005pmid:16043521
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Yeung ML,
    2. Yao Y,
    3. Jia L,
    4. Chan JF,
    5. Chan KH,
    6. Cheung KF,
    7. Chen H,
    8. Poon VK,
    9. Tsang AK,
    10. To KK,
    11. Yiu MK,
    12. Teng JL,
    13. Chu H,
    14. Zhou J,
    15. Zhang Q,
    16. Deng W,
    17. Lau SK,
    18. Lau JY,
    19. Woo PC,
    20. Chan TM,
    21. Yung S,
    22. Zheng BJ,
    23. Jin DY,
    24. Mathieson PW,
    25. Qin C,
    26. Yuen KY
    : MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat Microbiol 1: 16004, 2016pmid:27572168
    OpenUrlCrossRefPubMed
  8. ↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y,
    7. Zhang L,
    8. Fan G,
    9. Xu J,
    10. Gu X,
    11. Cheng Z,
    12. Yu T,
    13. Xia J,
    14. Wei Y,
    15. Wu W,
    16. Xie X,
    17. Yin W,
    18. Li H,
    19. Liu M,
    20. Xiao Y,
    21. Gao H,
    22. Guo L,
    23. Xie J,
    24. Wang G,
    25. Jiang R,
    26. Gao Z,
    27. Jin Q,
    28. Wang J,
    29. Cao B
    : Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497–506, 2020pmid:31986264
    OpenUrlCrossRefPubMed
  9. ↵
    1. Ronco C,
    2. Reis T
    : Kidney involvement in COVID-19 and rationale for extracorporeal therapies [published online ahead of print April 9, 2020]. Nat Rev Nephrol doi:10.1038/s41581-020-0284-7pmid:32273593
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 15 (7)
Clinical Journal of the American Society of Nephrology
Vol. 15, Issue 7
July 01, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Yue-miao Zhang, Hong Zhang
CJASN Jul 2020, 15 (7) 1044-1046; DOI: 10.2215/CJN.04370420

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Genetic Roadmap for Kidney Involvement of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Yue-miao Zhang, Hong Zhang
CJASN Jul 2020, 15 (7) 1044-1046; DOI: 10.2215/CJN.04370420
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Funding
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • A Body Size–Adjusted Maximum Ultrafiltration Rate Warning Level Is Not Equitable for Larger Patients
  • Food Insecurity and Kidney Disease
  • What Is the Best Maintenance Therapy for ANCA Vasculitis?
Show more Perspectives

Cited By...

  • Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal Interactions
  • Clinical Characteristics and Outcomes of COVID-19 patients with diabetes mellitus in Kuwait
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Keywords

  • COVID-19
  • kidney involvement
  • severe acute respiratory syndrome coronavirus 2
  • human ACE2
  • genetic perspective

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire